Price movement over the last 24 hours
Adaro Energy Indonesia Tbk vs Central Proteina Prima Tbk. — how do they compare? Adaro Energy Indonesia Tbk trades at Rp2,300 (market cap 69.07T, 19.18M 24h volume), while Central Proteina Prima Tbk. trades at Rp50 (market cap 2.98T, 3.7M 24h volume). The key difference: Adaro Energy Indonesia Tbk is far larger — about 23.2× Central Proteina Prima Tbk.'s market cap, and Adaro Energy Indonesia Tbk is more actively traded (19.18M versus 3.7M). Which is the better fit depends on your goals.
| ADRO | CPRO | |
|---|---|---|
Market Cap | 69.07T | 2.98T |
Volume | 19.18M | 3.7M |
Lot | 191.85K | 36.97K |
Turnover | 44.12B | 184.87M |
Average Price | 2,299.98 | 50 |
Value | 44.12B | 184.87M |
Indicative Equilibrium Price | 2,300 | 50 |
Indicative Equilibrium Volume | 21.49K | 405 |
Trailing returns across standard periods
Latest headlines on both assets
Adaro Energy , PT (the company) was established under its original name of PT Padang Karunia on Jul 28, 2004 then changed to PT Adaro Energy Tbk based on Notaries Deed dated Apr 18, 2008. The deed of establishment was approved by the the Ministry of Justice dated Apr 25, 2008.
Read more on ADRO →PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.
Read more on CPRO →